View of Budesonide-Glycopyrronium-Formoterol Fumarate Dihydrate (Breztri Aerosphere) | Canadian Journal of Health Technologies
![AstraZeneca's COPD triplet Breztri, rival to GSK's Trelegy, nabs first nod from Japan | Fierce Pharma AstraZeneca's COPD triplet Breztri, rival to GSK's Trelegy, nabs first nod from Japan | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1560954243/original.jpg/original.jpg?VersionId=cOPHe3AgrfC6J5YSBX9xbMiYh_9We8qS)
AstraZeneca's COPD triplet Breztri, rival to GSK's Trelegy, nabs first nod from Japan | Fierce Pharma
![AstraZeneca doubles down on animation—with a '60s spin this time—in new Breztri ad campaign | Fierce Pharma AstraZeneca doubles down on animation—with a '60s spin this time—in new Breztri ad campaign | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1613573051/Breztri%20Image%20Asset.jpg?VersionId=LIMQnkfSA7KSxDhs3A.xtgHhJaEQQhQ1)
AstraZeneca doubles down on animation—with a '60s spin this time—in new Breztri ad campaign | Fierce Pharma
![JCM | Free Full-Text | Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score JCM | Free Full-Text | Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score](https://www.mdpi.com/jcm/jcm-11-04491/article_deploy/html/images/jcm-11-04491-g001.png)